These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Percutaneous coronary intervention of or through saphenous vein grafts or internal mammary arteries: the impact of stents, adjunctive pharmacology, and multicomponent distal protection. Morrison DA; Thai H; Goldman S; Felix E; Hernandez J Catheter Cardiovasc Interv; 2006 Apr; 67(4):571-9. PubMed ID: 16547927 [TBL] [Abstract][Full Text] [Related]
5. In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry. Tolerico PH; Cohen DJ; Kleiman NS; Berger PB; Brilakis ES; Piana RN; Shammo S; Keyes MJ; Kennedy KF; Massaro JM; Saucedo JF; Catheter Cardiovasc Interv; 2012 Dec; 80(7):1127-36. PubMed ID: 22431166 [TBL] [Abstract][Full Text] [Related]
6. Percutaneous coronary interventions in patients with prior coronary artery bypass surgery: changes in patient characteristics and outcome during two decades. Mathew V; Clavell AL; Lennon RJ; Grill DE; Holmes DR Am J Med; 2000 Feb; 108(2):127-35. PubMed ID: 11126306 [TBL] [Abstract][Full Text] [Related]
7. Saphenous vein graft disease treated with the Wiktor Hepamed stent: procedural outcome, in-hospital complications and six-month angiographic follow-up. Van Langenhove G; Vermeersch P; Serrano P; Kutryk MJ; Stockman D; Convens C; Van den Branden F; Vanagt E; Albertal M; Van den Heuvel P Can J Cardiol; 2000 Apr; 16(4):473-80. PubMed ID: 10787462 [TBL] [Abstract][Full Text] [Related]
8. Comparison of sirolimus-eluting stents with paclitaxel-eluting stents in saphenous vein graft intervention (from a multicenter Southern California Registry). Lee MS; Hu PP; Aragon J; Shah AP; Oyama J; Dhoot J; Iqbal Z; Jones N; Penny W; Tobis J; Mahmud E; French W Am J Cardiol; 2010 Aug; 106(3):337-41. PubMed ID: 20643242 [TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of saphenous vein graft stenting compared with native coronary artery stenting in patients with previous coronary artery bypass graft surgery. Eid-Lidt G; Gaspar J; Adames AE; Damas de Los Santos F; Valdez R I; Ramírez-Gutiérrez AE; Martínez-Ríos MA Arch Cardiol Mex; 2010; 80(1):3-9. PubMed ID: 21147555 [TBL] [Abstract][Full Text] [Related]
11. Saphenous vein graft perforation during percutaneous coronary intervention: a case series. Marmagkiolis K; Brilakis ES; Hakeem A; Cilingiroglu M; Bilodeau L J Invasive Cardiol; 2013 Mar; 25(3):157-61. PubMed ID: 23468449 [TBL] [Abstract][Full Text] [Related]
12. Differential 1-year clinical outcomes for ST-segment elevation myocardial infarction related to stent thrombosis or saphenous vein graft thrombosis. Arzamendi D; Ly HQ; Tanguay JF; Armero S; Jilaihawi H; Gallo R; Ibrahim R; L'Allier P; Blondeau L; Gosselin G; Gregoire J; Doucet S Catheter Cardiovasc Interv; 2013 Aug; 82(2):193-200. PubMed ID: 21805615 [TBL] [Abstract][Full Text] [Related]
13. Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era. Pucelikova T; Mehran R; Kirtane AJ; Kim YH; Fahy M; Weisz G; Lansky AJ; Moussa I; Gray WA; Collins MB; Kodali SK; Stone GW; Moses JW; Leon MB; Dangas G Am J Cardiol; 2008 Jan; 101(1):63-8. PubMed ID: 18157967 [TBL] [Abstract][Full Text] [Related]
14. [Strategy for post coronary artery bypass grafting in patients with bypass graft stenosis: comparison of percutaneous transluminal coronary angioplasty for the native coronary artery, internal mammary artery and saphenous vein graft]. Kawaguchi R; Hoshizaki H; Oshima S; Ito S; Hiratsuji T; Tsurugaya H; Ito I; Sekiguchi M; Takama N; Seta Y; Adachi H; Toyama T; Naito S; Kaneko T; Taniguchi K J Cardiol; 2001 Nov; 38(5):239-44. PubMed ID: 11729723 [TBL] [Abstract][Full Text] [Related]
15. Optimizing dosimetry with high-dose intracoronary gamma radiation (21 Gy) for patients with diffuse in-stent restenosis. Kuchulakanti P; Torguson R; Canos D; Satler LF; Suddath W; Chan R; White LR; Gevorkian N; Bui A; Wang B; Kent KM; Pichard AD; Waksman R Cardiovasc Revasc Med; 2005; 6(3):108-12. PubMed ID: 16275606 [TBL] [Abstract][Full Text] [Related]
16. Chronic total occlusion treatment in post-CABG patients: saphenous vein graft versus native vessel recanalization-long-term follow-up in the drug-eluting stent era. Meliga E; García-García HM; Kukreja N; Daemen J; Tanimoto S; Ramcharitar S; van Mieghem CA; Sianos G; van der Ent M; van der Giessen WJ; de Feyter P; van Domburg R; Serruys PW Catheter Cardiovasc Interv; 2007 Jul; 70(1):21-5. PubMed ID: 17584913 [TBL] [Abstract][Full Text] [Related]
17. The use of drug-eluting stents in venous coronary artery bypass grafts. Hernandez-Antolín R; Alfonso F; Jimenez P EuroIntervention; 2009 May; 5 Suppl D():D51-7. PubMed ID: 19736072 [TBL] [Abstract][Full Text] [Related]
19. Clinical follow-up of paclitaxel-eluting (TAXUS) stents for the treatment of saphenous vein graft disease. Ruchin PE; Faddy SC; Muller DW; Baron DW; Roy PR; Wilson SH J Interv Cardiol; 2007 Aug; 20(4):258-64. PubMed ID: 17680855 [TBL] [Abstract][Full Text] [Related]
20. [Efficacy and outcome of primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction due to saphenous vein graft occlusion]. Ergelen M; Uyarel H; Gül M; Türer A; Yıldırım E; Bozbay M; Demirci D; Ersan D; Türkkan C; Uluganyan M; Tezel T Turk Kardiyol Dern Ars; 2010 Dec; 38(8):531-6. PubMed ID: 21248452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]